Is the WSJ biased against negative drug news?

Schwitzer seems to think so:

In today’s WSJ, the front page of the “Marketplace” section, page B1, has a story on the “blockbuster drug plavix” and a pack of new rivals on the horizon.

But negative findings on two other drug studies are relegated to pages B6 and B7, deep in the paper and deeper in that section.

Related posts:

1. Can a doctor sue a patient for a negative online review?
2. The exploding C-section rate in America
3. Gram negative superbugs
4. House Passes Prescription Drug Imports Bill
5. Aftermath of the UK drug trial disaster
6. Is the media biased against the pharmaceutical industry?
7. Can aspirin with Plavix be a new option to prevent stroke in atrial fibrillation?

  Follow on Twitter   Subscribe